Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Terminated NCT04734704

Defining the Role of the Skin Microbiome in Immune-related Adverse Events

Conditions: Vitiligo, Skin Melanoma

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 57
Sponsor: University Hospital, Bordeaux

Location: Service de Dermatologie - Hôpital Saint-André Bordeaux Bordeaux

Summary

The skin microbiome has been implicated in several cutaneous autoimmune pathologies such as psoriasis and atopic dermatitis. However, its role in vitiligo and vitiligo lesions occuring in patients receiving anti-PD-1 for metastatic melanoma

Eligibility Criteria

Inclusion Criteria: * Adult patients diagnosed with Vitiligo according to usual criteria. * Adult patients with metastatic melanoma, under anti-PD-1 who developed vitiligo * Adult patients with metastatic melanoma who did not develop Immune related adverse events under anti-PD-1 * Adult patients with metastatic melanoma who developed vitiligo under anti-PD-1 and discontinued the treatment * Free, informed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research). Exclusion Criteria: * Patients under 18 years old. * No treatment for vitiligo in the past 4 weeks * Patients under legal protection or unable to express their consent. * Patients not affiliated to a health insurance system. * Patients deprived of liberty by judiciary or administrative decision or hospitalized without consent or admitted in a sanitary or social institution for another reason than research.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04734704). StuddyBuddy aggregates publicly available trial information.